A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

计划入组 60 人 · 首次发布于 2015 年 8 月 20 日

WRAP North America

计划入组 250 人 · 首次发布于 2025 年 2 月 4 日

Screening Day Latin America

计划入组 1,162 人 · 首次发布于 2015 年 10 月 22 日

AdipoRaMab(Mitsubishi Tanabe Pharma)

aldosterone synthase inhibitors (Mitsubishi Tanabe Pharma)

glucokinase activators (Mitsubishi Tanabe Pharma)

Mitsubishi Tanabe Pharma America, Inc.

United States

MITSUBISHI TANABE PHARMA CORPORATION

Japan

MITSUBISHI TANABE PHARMA FACTORY LTD.

Japan

Mitsubishi Tanabe Pharma America to Present Breakthrough Neurodegenerative Disease Research at AAN 2025

SparX Biopharmaceutical and Mitsubishi Tanabe Pharma America Partner on Novel Immune Cell-Targeting ADC Program

Shionogi Acquires RADICAVA Business from Tanabe Pharma for $2.5 Billion to Strengthen Rare Disease Portfolio